LOXL2 and cancer: The findings of previous studies have shown that LOXL2 is highly expressed in a variety of cancers in humans including head and neck squamous cell carcinoma, breast, colon, skin, and gastric cancer, and its high expression correlates with metastasis and poor prognosis23,34–37.